Author Index

Search or browse for an author across our entire electronic archive

Search results for: J
Results 1 - 10 of 621 shown below

  • J H Olsen,

    J F Winther, J D Boice, B L Thomsen, W J Schull, M Stovall and J H Olsen

    Sex ratio among offspring of childhood cancer survivors treated with radiotherapy

    doi:10.1038/sj.bjc.6600748

  • Jäckel, A

    M Deichmann, M Thome, M Bock, A Jäckel, V Waldmann and H Näher

    The human herpesvirus-type 8 is not involved in malignant melanoma

    doi:10.1038/sj.bjc.6690322

  • Jäckel, S

    F Austrup, P Uciechowski, C Eder, B Böckmann, B Suchy, G Driesel, S Jäckel, I Kusiak, H-J Grill and M Giesing

    Prognostic value of genomic alterations in minimal residual cancer cells purified from the blood of breast cancer patients

    doi:10.1054/bjoc.2000.1501

  • Jäger, C

    G Kristiansen, F R Fritzsche, K Wassermann, C Jäger, A Tölle, M Lein, C Stephan, K Jung, C Pilarsky, M Dietel and H Moch

    GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics

    doi:10.1038/sj.bjc.6604614

  • Jäger, D

    J Schmidt, T Welsch, D Jäger, P F Mühlradt, M W Büchler and A Märten

    Intratumoural injection of the toll-like receptor-2/6 agonist 'macrophage-activating lipopeptide-2' in patients with pancreatic carcinoma: a phase I/II trial

    advance online publication, 2007-07-31 00:00:00.000;

    doi:10.1038/sj.bjc.6603903

  • Jäger, E

    A Atmaca, S-E Al-Batran, A Maurer, A Neumann, T Heinzel, B Hentsch, S E Schwarz, S Hövelmann, M Göttlicher, A Knuth and E Jäger

    Valproic acid (VPA) in patients with refractory advanced cancer: a dose escalating phase I clinical trial

    advance online publication, 2007-06-19 00:00:00.000;

    doi:10.1038/sj.bjc.6603851

  • Jäger, H R

    P-J Lou, H R Jäger, L Jones, T Theodossy, S G Bown and C Hopper

    Interstitial photodynamic therapy as salvage treatment for recurrent head and neck cancer

    advance online publication, 2004-07-06 00:00:00.000;

    doi:10.1038/sj.bjc.6601993

  • Jäger, M

    D O Watermann, B Gabriel, M Jäger, M Orlowska-Volk, A Hasenburg, A zur Hausen, G Gitsch and E Stickeler

    Specific induction of pp125 focal adhesion kinase in human breast cancer

    advance online publication, 2005-08-23 00:00:00.000;

    doi:10.1038/sj.bjc.6602744

  • P Ruf, O Gires, M Jäger, K Fellinger, J Atz and H Lindhofer

    Characterisation of the new EpCAM-specific antibody HO-3: implications for trifunctional antibody immunotherapy of cancer

    advance online publication, 2007-07-10 00:00:00.000;

    doi:10.1038/sj.bjc.6603881

  • Jäger, R

    R Jäger, B List, C Knabbe, B Souttou, D Raulais, T Zeiler, A Wellstein, A Aigner, A Neubauer and G Zugmaier

    Serum levels of the angiogenic factor pleiotrophin in relation to disease stage in lung cancer patients

    doi:10.1038/sj.bjc.6600202

  • H-H Heidtmann, D M Nettelbeck, A Mingels, R Jäger, H-G Welker and R E Kontermann

    Generation of angiostatin-like fragments from plasminogen by prostate-specific antigen

    doi:10.1038/sj.bjc.6692167

  • Jäger, U

    M Raderer, T Traub, M Formanek, I Virgolini, C Österreicher, W Fiebiger, M Penz, U Jäger, J Pont, A Chott and A Kurtaran

    Somatostatin-receptor scintigraphy for staging and follow-up of patients with extraintestinal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT)-type

    doi:10.1054/bjoc.2001.2070